H

Hyundai Bioscience Co Ltd
KOSDAQ:048410

Watchlist Manager
Hyundai Bioscience Co Ltd
KOSDAQ:048410
Watchlist
Price: 14 490 KRW -0.55% Market Closed
Market Cap: 577B KRW
Have any thoughts about
Hyundai Bioscience Co Ltd?
Write Note

Intrinsic Value

Hyundai Bioscience Co Ltd's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one Hyundai Bioscience Co Ltd stock under the Base Case scenario is 501.94 KRW. Compared to the current market price of 14 490 KRW, Hyundai Bioscience Co Ltd is Overvalued by 97%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
501.94 KRW
Overvaluation 97%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation Backtest
Hyundai Bioscience Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Hyundai Bioscience Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Hyundai Bioscience Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Hyundai Bioscience Co Ltd

Provide an overview of the primary business activities
of Hyundai Bioscience Co Ltd.

What unique competitive advantages
does Hyundai Bioscience Co Ltd hold over its rivals?

What risks and challenges
does Hyundai Bioscience Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Hyundai Bioscience Co Ltd.

Provide P/S
for Hyundai Bioscience Co Ltd.

Provide P/E
for Hyundai Bioscience Co Ltd.

Provide P/OCF
for Hyundai Bioscience Co Ltd.

Provide P/FCFE
for Hyundai Bioscience Co Ltd.

Provide P/B
for Hyundai Bioscience Co Ltd.

Provide EV/S
for Hyundai Bioscience Co Ltd.

Provide EV/GP
for Hyundai Bioscience Co Ltd.

Provide EV/EBITDA
for Hyundai Bioscience Co Ltd.

Provide EV/EBIT
for Hyundai Bioscience Co Ltd.

Provide EV/OCF
for Hyundai Bioscience Co Ltd.

Provide EV/FCFF
for Hyundai Bioscience Co Ltd.

Provide EV/IC
for Hyundai Bioscience Co Ltd.

Compare the intrinsic valuations
of Hyundai Bioscience Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Hyundai Bioscience Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Hyundai Bioscience Co Ltd compared to its peers.

Compare the P/E ratios
of Hyundai Bioscience Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Hyundai Bioscience Co Ltd with its peers.

Analyze the financial leverage
of Hyundai Bioscience Co Ltd compared to its main competitors.

Show all profitability ratios
for Hyundai Bioscience Co Ltd.

Provide ROE
for Hyundai Bioscience Co Ltd.

Provide ROA
for Hyundai Bioscience Co Ltd.

Provide ROIC
for Hyundai Bioscience Co Ltd.

Provide ROCE
for Hyundai Bioscience Co Ltd.

Provide Gross Margin
for Hyundai Bioscience Co Ltd.

Provide Operating Margin
for Hyundai Bioscience Co Ltd.

Provide Net Margin
for Hyundai Bioscience Co Ltd.

Provide FCF Margin
for Hyundai Bioscience Co Ltd.

Show all solvency ratios
for Hyundai Bioscience Co Ltd.

Provide D/E Ratio
for Hyundai Bioscience Co Ltd.

Provide D/A Ratio
for Hyundai Bioscience Co Ltd.

Provide Interest Coverage Ratio
for Hyundai Bioscience Co Ltd.

Provide Altman Z-Score Ratio
for Hyundai Bioscience Co Ltd.

Provide Quick Ratio
for Hyundai Bioscience Co Ltd.

Provide Current Ratio
for Hyundai Bioscience Co Ltd.

Provide Cash Ratio
for Hyundai Bioscience Co Ltd.

What is the historical Revenue growth
over the last 5 years for Hyundai Bioscience Co Ltd?

What is the historical Net Income growth
over the last 5 years for Hyundai Bioscience Co Ltd?

What is the current Free Cash Flow
of Hyundai Bioscience Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Hyundai Bioscience Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hyundai Bioscience Co Ltd

Current Assets 16.2B
Cash & Short-Term Investments 3.9B
Receivables 5.5B
Other Current Assets 6.8B
Non-Current Assets 37.6B
Long-Term Investments 1.6B
PP&E 2.8B
Intangibles 31.2B
Other Non-Current Assets 2B
Current Liabilities 6.7B
Accounts Payable 407m
Accrued Liabilities 228.6m
Short-Term Debt 5.4B
Other Current Liabilities 681.4m
Non-Current Liabilities 602.9m
Long-Term Debt 9.2m
Other Non-Current Liabilities 593.7m
Efficiency

Earnings Waterfall
Hyundai Bioscience Co Ltd

Revenue
9.2B KRW
Cost of Revenue
-5B KRW
Gross Profit
4.3B KRW
Operating Expenses
-12.5B KRW
Operating Income
-8.2B KRW
Other Expenses
1.6B KRW
Net Income
-6.6B KRW

Free Cash Flow Analysis
Hyundai Bioscience Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hyundai Bioscience Co Ltd's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
ROIC is Increasing
Positive 3-Years Revenue Growth
23/100
Profitability
Score

Hyundai Bioscience Co Ltd's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hyundai Bioscience Co Ltd's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
64/100
Solvency
Score

Hyundai Bioscience Co Ltd's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hyundai Bioscience Co Ltd

There are no price targets for Hyundai Bioscience Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Hyundai Bioscience Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Hyundai Bioscience Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Hyundai Bioscience Co Ltd

Country

Korea

Industry

Consumer products

Market Cap

577B KRW

Dividend Yield

0%

Description

HYUNDAI BIOSCIENCE Co., Ltd. engages in the manufacture and sale of bio-cosmetics and hair tonics. The company is headquartered in Gimcheon, Gyeongsangbuk-Do. The company went IPO on 2002-08-08. The company develops functional daily necessities such as shampoos, mask packs, creams, and tumor-targeted drug. The firm also sells liquid crystal display (LCD) monitors and digital signage display products. The firm distributes its products in domestic market, as well as to the overseas markets, including Europe, America and Japan.

Contact

GYEONGSANGBUK-DO
Gimcheon
106, Apogongdan-gil, Apo-eup
+827070080141
www.hyundaibioscience.com

IPO

2002-08-08 00:00:00

Employees

-

Officers

Joint Chief Executive Officer
Ho-Suk Chon
President
Yeong-Jin Kim
Chief Operating Officer and Senior Managing Director
Seok-Yong Choi

See Also

Discover More
What is the Intrinsic Value of one Hyundai Bioscience Co Ltd stock?

The intrinsic value of one Hyundai Bioscience Co Ltd stock under the Base Case scenario is 501.94 KRW.

Is Hyundai Bioscience Co Ltd stock undervalued or overvalued?

Compared to the current market price of 14 490 KRW, Hyundai Bioscience Co Ltd is Overvalued by 97%.

Back to Top